Cart
sales@molnova.com
Cefoselis Sulfate
CAS No. 122841-12-7
Cefoselis Sulfate( Winsef )
Catalog No. M17204 CAS No. 122841-12-7
Cefoselis is a widely used beta-lactam antibiotic.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 75 | In Stock |
|
| 2MG | 32 | In Stock |
|
| 5MG | 50 | In Stock |
|
| 10MG | 76 | In Stock |
|
| 25MG | 140 | In Stock |
|
| 50MG | 219 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCefoselis Sulfate
-
NoteResearch use only, not for human use.
-
Brief DescriptionCefoselis is a widely used beta-lactam antibiotic.
-
DescriptionCefoselis sulfate is a stable cephalosporin for BETA-lactamase. The drug shows antimicrobial activity for a wide range of bacteria including Pseudomonas.(In Vitro):The activity of Cefoselis (sulfate) was similar to that of cefpirome and cefepime and generally superior to that of ceftazidime. Cefoselis sulfate showed potent antibacterial activity against Hemophilus influenzae and Moraxella catarrhalis. Cefoselis sulfate was highly active against MSSA and MSCNS. Cefoselis sulfate was poor in the activity against MRSA, MRCNS,PRSP and Enterococcus faecalis,and no activity for Enterococcus faecium.
-
In VitroThe activity of Cefoselis (sulfate) was similar to that of cefpirome and cefepime and generally superior to that of ceftazidime. Cefoselis sulfate showed potent antibacterial activity against Hemophilus influenzae and Moraxella catarrhalis.Cefoselis sulfate was highly active against MSSA and MSCNS. Cefoselis sulfate was poor in the activity against MRSA, MRCNS,PRSP and Enterococcus faecalis,and no activity for Enterococcus faecium.
-
In Vivo——
-
SynonymsWinsef
-
PathwayAutophagy
-
TargetCXCR
-
RecptorOthers
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number122841-12-7
-
Formula Weight620.64
-
Molecular FormulaC19H22N8O6S2·H2SO4
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 6.4 mg/mL. 10.31 mM
-
SMILESCO/N=C(\C1=CSC(=N1)N)/C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)CN4C=CC(=N)N4CCO)C(=O)O.OS(=O)(=O)O
-
Chemical Name(6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((2-(2-hydroxyethyl)-3-imino-2,3-dihydro-1H-pyrazol-1-yl)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid compound with sulfuric acid (1:1)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sugimoto M, et al. Br J Pharmacol, 2002, 135(2), 427-432.
molnova catalog
related products
-
FC131 TFA
FC131 TFA is an antagonist of CXCR4 that inhibits the binding of [125I] -sdf-1 to CXCR4(IC50 : 4.5 nM ), and has anti-hiv activity.
-
USL311
USL311 is a CXCR4 receptor antagonist which prevents the binding of stromal-cell derived factor-1 (SDF-1 or CXCL12) to CXCR4.?USL311 inhibits CXCR4 activation and decreases proliferation and migration of CXCR4-expressing tumor cells, with anti-tumor activity.
-
AMG 487
AMG 487 prevents the chemokines I-IP-10 and I-ITAC from binding to CXCR3.?In the cellular assays, AMG 487 inhibits CXCR3-mediated cell migration with IC50 values of 8nM, 15nM and 36nM for I-IP-10, I-ITAC and MIG, respectively.
